Statin therapy and cognitive deficits associated with neurofibromatosis type 1. Jansen, J. F. JAMA, 300(20):2369; author reply 2369-70, 2008. Jansen, Jacobus F A eng Comment Letter 2008/11/27 09:00 JAMA. 2008 Nov 26;300(20):2369; author reply 2369-70. doi: 10.1001/jama.2008.687.
Statin therapy and cognitive deficits associated with neurofibromatosis type 1 [link]Paper  doi  bibtex   
@article{RN129,
   author = {Jansen, J. F.},
   title = {Statin therapy and cognitive deficits associated with neurofibromatosis type 1},
   journal = {JAMA},
   volume = {300},
   number = {20},
   pages = {2369; author reply 2369-70},
   note = {Jansen, Jacobus F A
eng
Comment
Letter
2008/11/27 09:00
JAMA. 2008 Nov 26;300(20):2369; author reply 2369-70. doi: 10.1001/jama.2008.687.},
   keywords = {Animals
Child
Cognition/*drug effects
Disease Models, Animal
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use
Mice
Mice, Neurologic Mutants
Neurofibromatosis 1/*drug therapy
Simvastatin/*therapeutic use},
   ISSN = {1538-3598 (Electronic)
0098-7484 (Linking)},
   DOI = {10.1001/jama.2008.687},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/19033585
https://jamanetwork.com/journals/jama/article-abstract/182959},
   year = {2008},
   type = {Journal Article}
}

Downloads: 0